PB28, the Sigma-1 and Sigma-2 Receptors Modulator With Potent Anti–SARS-CoV-2 Activity: A Review About Its Pharmacological Properties and Structure Affinity Relationships
These unprecedented times have forced the scientific community to gather to face the COVID-19 pandemic. Efforts in diverse directions have been made. A multi-university team has focused on the identification of the host (human) proteins interacting with SARS-CoV-2 viral proteins, with the aim of ham...
Main Authors: | Carmen Abate, Mauro Niso, Francesca Serena Abatematteo, Marialessandra Contino, Nicola Antonio Colabufo, Francesco Berardi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.589810/full |
Similar Items
-
Multi-Target Directed Ligands (MTDLs) Binding the σ<sub>1</sub> Receptor as Promising Therapeutics: State of the Art and Perspectives
by: Francesca Serena Abatematteo, et al.
Published: (2021-06-01) -
Editorial: Sigma Receptors
by: Ebru Aydar, et al.
Published: (2020-08-01) -
The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception
by: Pilar Sánchez-Blázquez, et al.
Published: (2020-11-01) -
The Roles of Intracellular Chaperone Proteins, Sigma Receptors, in Parkinson’s Disease (PD) and Major Depressive Disorder (MDD)
by: Kai Yang, et al.
Published: (2019-05-01) -
A Structure- and Ligand-Based Virtual Screening of a Database of “Small” Marine Natural Products for the Identification of “Blue” Sigma-2 Receptor Ligands
by: Giuseppe Floresta, et al.
Published: (2018-10-01)